Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA –...

Syensqo recently announced a strategic five-year partnership with Bota Bio, a global industrial biotechnology company specializing in biomanufactured, clean, and high...

Germany-headquartered Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of...

In a move to expand its global biomanufacturing network, US biopharma Amgen is planning to invest $1 billion to build a second drug substance manufacturing facility at...

Samsung Biologics, a global contract development and manufacturing organization (CDMO), recently announced a series of manufacturing deals with a Europe-based...

Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2)...

Dinamiqs, a company specializing in the development and production of viral vectors and part of the Swiss Siegfried Group since May 2023, has inaugurated its new research...

Lonza, a global contract development and manufacturing organization (CDMO) for the pharmaceutical, biotech, and nutraceutical markets, announced today that it will invest...